Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Lilly and Biolojic Design sign diabetes therapy research collaboration
Eli Lilly and Biolojic Design signed a research collaboration and license agreement to discover and develop an antibody-based therapy for diabetes. Lilly will use Biolojic’s AI-based platform to discover a multi-specific antibody.